Cart
sales@molnova.com
Grapiprant
CAS No. 415903-37-6
Grapiprant( CJ-023423 | AAT-007 )
Catalog No. M14424 CAS No. 415903-37-6
A novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 75 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 187 | In Stock |
|
| 50MG | 346 | In Stock |
|
| 100MG | 523 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGrapiprant
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation.
-
DescriptionA novel EP4 antagonist; an analgesic and anti-inflammatory drug in the piprant class that was approved for Veterinary Medicine for the control of pain and inflammation associated with osteoarthritis (OA) in dogs.Pain Phase 2 Clinical(In Vivo):Grapiprant (0-50 mg/kg; oral administration; every 24 hours; for 9 months; beagles) is safe for dogs by long-term oral administration. Efficacy of Grapiprant in the treatment of dogs with osteoarthritis needs to be evaluated in other studies.
-
In Vitro——
-
In VivoGrapiprant (0-50 mg/kg; oral administration; every 24 hours; for 9 months; beagles) is safe for dogs by long-term oral administration. Efficacy of Grapiprant in the treatment of dogs with osteoarthritis needs to be evaluated in other studies . Animal Model:36 beagles of both sexes (9-month-old) Dosage:0 mg/kg, 1 mg/kg, 6 mg/kg, or 50 mg/kg Administration:Oral administration; every 24 hours; for 9 months Result:Long-term oral administration was safe for dogs.
-
SynonymsCJ-023423 | AAT-007
-
PathwayGPCR/G Protein
-
TargetProstaglandin Receptor
-
RecptorProstaglandin Receptor
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number415903-37-6
-
Formula Weight491.6052
-
Molecular FormulaC26H29N5O3S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NCCC1=CC=C(C=C1)N2C(CC)=NC3=C(N=C(C=C32)C)C)NS(C4=CC=C(C=C4)C)(=O)=O
-
Chemical NameBenzenesulfonamide, N-[[[2-[4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino]carbonyl]-4-methyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rausch-Derra LC, et al. Am J Vet Res. 2015 Oct;76(10):853-9.
2. Rausch-Derra LC, et al. J Vet Pharmacol Ther. 2016 Dec;39(6):566-571.
3. De Vito V, et al. J Pharm Biomed Anal. 2016 Jan 25;118:251-8.
molnova catalog
related products
-
7-demethylsuberosin
7-demethylsuberosin?is a coumarin compound isolated from Angelica gigas Nakaiand has anti-inflammatory activityand exhibited ?inhibitory effects on PGE2 production with the IC50 values of 9.42 μM.
-
Saikogenin D
Saikogenin D is isolated from?Bupleurum chinense, has anti-inflammatory effects. Saikogenin D activates epoxygenases that converts arachidonic acid to epoxyeicosanoids and dihydroxyeicosatrienoic acids, and the metabolites secondarily inhibit prostaglandin E2 (PGE2) production. Saikogenin D results in an elevation of [Ca2+]i due to Ca2+ release from intracellular stores.
-
Imidapril HCl
Imidapril HCl is an angiotensin-converting enzyme (ACE) inhibitor with IC50 of 2.6 nM, used for the treatment of hypertension.
